News
We will be attending the PDA – Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference, Palm Springs, CA. Come and visit us in Booth #222 & 224.
More...We supported the Women in STEM campaign that launched on 23rd June within the New Scientist and online at https://bit.ly/3aRT4mG Women in STEM looked at the pivotal role that women…
More...SMC announces the opening of Cambridge Pharma a new business offering pharmaceutical development services, including sterile fill-finish. The new 20,000 sq ft facility located at the Cambridge Research Park, UK, includes a…
More...Watch a recording Alex Vasiev’s presentation “Enabling a flexible autoinjector platform for the delivery of high viscosity or large volume parenteral formulations” here.
More...Oval’s Alex Vasiev will be presenting at this year’s DDF Summit. Join from 11.25 – 12.00 on 15th of March to hear his talk, Meeting the Challenge of Delivering High…
More...Read our article on ArQ – Bios, our flexible patient-centric autoinjector for high/ultrahigh viscosity or high volume, in Health Europa here.
More...We wish our colleagues and friends around the world a happy and safe holiday season and a wonderful New Year.
More...Oval will be virtually attending BIO-Europe Oct 2020. BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors.…
More...Cambridge U.K. – 19 August 2019 Oval Medical Technologies Limited (Oval), a leader of patient-centric autoinjectors, has signalled a new stage in its growth with a move to a purpose-designed…
More...Oval will be attending BIO-Europe in Copenhagen from the 5th-7th November 2018. BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology,…
More...